NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Novus Diagnostics

Novus Diagnostics

Private
DublinHealthcare & Life Scienceshttps://novus-dx.com/

Last Round

Series A

Oct 25, 2024

Est. Valuation

$20M

Total Funding Raised

$14M

Company Overview

Novus Diagnostics is a medical device company that develops rapid point-of-care diagnostic solutions for the detection and classification of infectious diseases, specifically sepsis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

sepsis diagnosticspoint-of-care testingPOCTmicrofluidic sensorsbedside diagnosticspathogen identificationmedical devicediagnostic softwarerazor-razorblade modelclinical diagnosticsinfectious disease testingmedtechrapid testingAI diagnosticsbloodstream infection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novus Diagnostics Comps

Public and private peers based on sector, stage, and business model.

Novus Diagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Novus Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 25, 2024
VC RoundNov 21, 2022
GrantJan 12, 2021

Key People

Founding team and executive leadership

Elaine Spain

COO CO-Founder

Founding Team

Kellie Adamson

Co-Founder & Chief Scientific Officer

Founding Team

Novus Diagnostics Investors

Notable investors and investment history

Novus Diagnostics investors
InvestorRounds
Business Venture PartnersSeries A
Irrus InvestmentsSeries A
European Innovation Council FundVC Round, Grant
Enterprise IrelandVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 25, 2024

    $5M round led by Business Venture Partners, Irrus Investments, and Trinity Biotech plc.

  • Apr 9, 2024

    Grew 23% QoQ, from 13 to 16 employees.

Novus Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Novus Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novus Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDublin
Employee Range23
Year Founded2016
Last FundingOct 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.